As of Feb 05
| -1.54 / -1.78%|
The 20 analysts offering 12-month price forecasts for Gilead Sciences have a median target of 120.00, with a high estimate of 137.00 and a low estimate of 91.00. The median estimate represents a +40.94% increase from the last price of 85.14.
The current consensus among 25 polled investment analysts is to Buy stock in Gilead Sciences. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.